236 related articles for article (PubMed ID: 26287771)
1. Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis.
Li X; Ma X; Chen L; Gu L; Zhang Y; Zhang F; Ouyang Y; Gao Y; Huang Q; Zhang X
Sci Rep; 2015 Aug; 5():13157. PubMed ID: 26287771
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.
Cheng B; Yang G; Jiang R; Cheng Y; Yang H; Pei L; Qiu X
Oncotarget; 2016 Oct; 7(40):65862-65875. PubMed ID: 27588469
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and Clinicopathological Significance of Survivin Expression in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Xie Y; Ma X; Gu L; Li H; Chen L; Li X; Gao Y; Fan Y; Zhang Y; Yao Y; Zhang X
Sci Rep; 2016 Jul; 6():29794. PubMed ID: 27411378
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and clinicopathological role of high Ki-67 expression in patients with renal cell carcinoma: a systematic review and meta-analysis.
Xie Y; Chen L; Ma X; Li H; Gu L; Gao Y; Fan Y; Zhang Y; Zhang X
Sci Rep; 2017 Mar; 7():44281. PubMed ID: 28287186
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of CD44 is associated with more aggressive behavior in clear cell renal cell carcinoma.
Zanjani LS; Madjd Z; Abolhasani M; Rasti A; Fodstad O; Andersson Y; Asgari M
Biomark Med; 2018 Jan; 12(1):45-61. PubMed ID: 29243496
[TBL] [Abstract][Full Text] [Related]
6. Phosphatase and tensin homolog (PTEN) expression on oncologic outcome in renal cell carcinoma: A systematic review and meta-analysis.
Tang L; Li X; Gao Y; Chen L; Gu L; Chen J; Lyu X; Zhang Y; Zhang X
PLoS One; 2017; 12(7):e0179437. PubMed ID: 28672019
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinicopathological significance of PD-L1 in patients with renal cell carcinoma: a meta-analysis based on 1863 individuals.
Wang Z; Peng S; Xie H; Guo L; Cai Q; Shang Z; Jiang N; Niu Y
Clin Exp Med; 2018 May; 18(2):165-175. PubMed ID: 29362922
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of Cyclin D1 Expression in Renal Cell Carcinoma: a Systematic Review and Meta-analysis.
Li Z; Liu J; Zhang X; Fang L; Zhang C; Zhang Z; Yan L; Tang Y; Fan Y
Pathol Oncol Res; 2020 Jul; 26(3):1401-1409. PubMed ID: 31748879
[TBL] [Abstract][Full Text] [Related]
9. Analysis of CD44 isoform v10 expression and its prognostic value in renal cell carcinoma.
Li N; Tsuji M; Kanda K; Murakami Y; Kanayama H; Kagawa S
BJU Int; 2000 Mar; 85(4):514-8. PubMed ID: 10691836
[TBL] [Abstract][Full Text] [Related]
10. BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma.
Sekino Y; Han X; Kobayashi G; Babasaki T; Miyamoto S; Kobatake K; Kitano H; Ikeda K; Goto K; Inoue S; Hayashi T; Teishima J; Sakamoto N; Sentani K; Oue N; Yasui W; Matsubara A
Oncology; 2021; 99(4):240-250. PubMed ID: 33588420
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis.
Hu Q; Gou Y; Sun C; Ding W; Xu K; Gu B; Xia G; Ding Q
Urol Oncol; 2014 Jan; 32(1):50.e1-8. PubMed ID: 24239465
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of CD44 cell adhesion molecule expression in primary and metastatic renal cell carcinoma: a clinicopathologic study of 125 cases.
Lim SD; Young AN; Paner GP; Amin MB
Virchows Arch; 2008 Jan; 452(1):49-55. PubMed ID: 18026989
[TBL] [Abstract][Full Text] [Related]
13. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice.
Bedke J; Heide J; Ribback S; Rausch S; de Martino M; Scharpf M; Haitel A; Zimmermann U; Pechoel M; Alkhayyat H; Shariat SF; Dombrowski F; Stenzl A; Burchardt M; Klatte T; Kroeger N
BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value and clinicopathological significance of CD44 expression in ovarian cancer: a meta-analysis.
Zhao L; Gu C; Huang K; Zhang Z; Ye M; Fan W; Han W; Meng Y
Arch Gynecol Obstet; 2016 Nov; 294(5):1019-1029. PubMed ID: 27300001
[TBL] [Abstract][Full Text] [Related]
15. Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis.
Chen J; Zhou J; Lu J; Xiong H; Shi X; Gong L
BMC Cancer; 2014 Jan; 14():15. PubMed ID: 24410905
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma.
Yildiz E; Gokce G; Kilicarslan H; Ayan S; Goze OF; Gultekin EY
BJU Int; 2004 May; 93(7):1087-93. PubMed ID: 15142169
[TBL] [Abstract][Full Text] [Related]
17. CD44 expression is predictive of poor prognosis in pharyngolaryngeal cancer: systematic review and meta-analysis.
Chai L; Liu H; Zhang Z; Wang F; Wang Q; Zhou S; Wang S
Tohoku J Exp Med; 2014 Jan; 232(1):9-19. PubMed ID: 24429392
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and clinicopathological value of PBRM1 expression in renal cell carcinoma.
Wang Z; Peng S; Guo L; Xie H; Wang A; Shang Z; Niu Y
Clin Chim Acta; 2018 Nov; 486():9-17. PubMed ID: 30006290
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of CD44 expression in oral squamous cell carcinoma: A meta-analysis.
Mirhashemi M; Sadeghi M; Ghazi N; Saghravanian N; Dehghani M; Aminian A
Ann Diagn Pathol; 2023 Dec; 67():152213. PubMed ID: 37856951
[TBL] [Abstract][Full Text] [Related]
20. Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis.
Pu Z; Wang Q; Xie H; Wang G; Hao H
Oncotarget; 2017 Mar; 8(12):19825-19833. PubMed ID: 28178644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]